Skip to main content
FinSpry Logo
FinSpry
VCEL logo
VCEL
(NASDAQ)
Vericel Corporation
$45.05-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Vericel (VCEL) Stock Price & Financial Analysis

Vericel Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$43.95 - $45.19
52-Week High$48.75
52-Week Low$28.95
Open$44.24
Volume715.02K
Average Volume (3M)647.84K
Market Cap2.29B
Shares Outstanding50.77M
P/E Ratio (TTM)106.56
Forward P/E53.82
Price to Sales (P/S)7.83
Price to Book (P/B)6.42
EV/EBITDA64.44
Revenue (TTM)292.09M
Net Income (TTM)21.46M
Free Cash Flow (TTM)35.46M
EPS (TTM)$0.42
Profit Margin7.35%
Operating Margin5.40%
Return on Equity (ROE)6.02%
Debt to Equity0.27
50-Day MA$40.10
200-Day MA$37.00
52-Week Change11.64%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Vericel

What is the current stock price for VCEL?

As of the latest trading session, VCEL stock trades at $45.05. The 52-week range is $28.95–$48.75, with a day range of $43.95–$45.19.

What is the P/E ratio for VCEL?

Vericel's trailing P/E ratio is 106.6, meaning investors pay $106.6 for every $1 of annual earnings. The forward P/E is 53.8, reflecting analyst expectations for future earnings. Vericel operates in the Healthcare sector.

Does VCEL pay dividends?

Vericel does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VCEL?

Based on 4 analysts, the consensus for VCEL is Buy.

What is the market cap of VCEL?

Vericel's market capitalization is $2.29B, classifying it as a mid-cap company. Vericel operates in the Healthcare sector within the Biotechnology industry.